U.K. to pull linear gadolinium MRI agents by February
December 15, 2017 -- Two widely used linear gadolinium MRI contrast agents will be pulled from the U.K. market by 1 February, while the use of other linear agents will be restricted to limited indications, according to an announcement by the U.K.'s Medicine and Healthcare products Regulatory Agency (MHRA).  Discuss
First-in-human data validate MRI-guided radiotherapy
December 5, 2017 -- A research team at the University Medical Center Utrecht in the Netherlands has published details of the first four patient treatments using a new MRI-guided radiotherapy system demonstrates the feasibility and clinical utility of the MRI-linac system.  Discuss
Why EMA's relocation is good news for radiology
December 1, 2017 -- The European Medicines Agency (EMA) is relocating from London to Amsterdam, but does this really matter? Yes it does, Dr. Hildo Lamb wrote in a guest column. He's convinced the move will lead to a host of new opportunities for the medical imaging community.  Discuss
MRI technique may help diagnose migraine headaches
November 30, 2017 -- While painful and often debilitating for patients, migraines can also be difficult to diagnose and differentiate from other types of headaches. An MRI technique may help alleviate that diagnostic challenge, according to research presented on November 28 at the RSNA 2017 meeting in Chicago.  Discuss
PET/CT, MRI foretell developing neurofibromas
November 28, 2017 -- CHICAGO - Researchers from Spain are following the adage "forewarned is forearmed" by using PET/CT and MRI to predict which lesions could progress to malignant neurofibromas. They presented their findings on Sunday at RSNA 2017.  Discuss
Gadolinium: EU nations get 1 year to implement EMA ruling
November 27, 2017 -- The European Commission has adopted the decision of the European Medicines Agency (EMA) on linear gadolinium-based contrast agents, but with one important amendment: European Union (EU) member states will have up to a year to implement the ruling.  Discuss
MRI discovers heart damage among male triathletes
November 24, 2017 -- Using late gadolinium-enhanced MRI scans, German researchers found myocardial fibrosis, or scarring of the heart, among competitive male triathletes. An increased risk of scarring was associated with the amount of exercise performed, according to the group, who will present the study at next week's RSNA meeting in Chicago.  Discuss
Dutch radiologists welcome EU vote on EMA relocation
November 20, 2017 -- After a dramatic day of twists and turns and three rounds of voting on 20 November, the European Union (EU) chose Amsterdam as the new home of the European Medicines Agency (EMA). Dutch radiologists are welcoming the decision to relocate 900 staff from London to Amsterdam.  Discuss
GBCA study contradicts past gadolinium retention results
November 16, 2017 -- In results they described as "unexpected" and "controversial," Norwegian researchers found levels of residual signal enhancement in the brains of 17 patients who were given a macrocyclic gadolinium-based contrast agent (GBCA), with the highest levels found in two patients who received the most doses, according to a paper in the November issue of Radiology.  Discuss
MRI becomes safer for patients with heart-valve prosthesis
November 13, 2017 -- Evidence about the use of MRI in patients with a heart-valve prosthesis remains inconclusive, but the latest data support the hypothesis of a low or negligible interaction with MRI, according to research from the European Society of Cardiovascular Radiology congress in Milan.  Discuss